Compare Alibaba Group (BABA) vs Bristol-Myers Squibb Co (BMY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alibaba Group vs Bristol-Myers Squibb Co — how do they compare? Alibaba Group trades at $125.7 (market cap $308.93B), while Bristol-Myers Squibb Co trades at $63.41 (market cap $129.94B). The key difference: Alibaba Group is far larger — about 2.4× Bristol-Myers Squibb Co's market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BABA | BMY | |
|---|---|---|
Market Cap | $308.93B | $129.94B |
Volume | 18,069,938 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $189.34 | $65.89 |
52-Week Low | $94.83 | $42.60 |
Enterprise Value | $303.72B | $163.92B |
Dividend Yield | 0.82% | 3.96% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alibaba Group
Alibaba Group Holding Limited operates as a holding company. The Company provides internet infrastructure, electronic commerce, online financial, and internet content services through its subsidiaries. Alibaba Group Holding offers its products and services worldwide.
Read more on BABA →About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →
